Envoy Medical, Inc. (COCH)
NASDAQ: COCH · Real-Time Price · USD
0.8476
+0.0259 (3.15%)
At close: Dec 10, 2025, 4:00 PM EST
0.8307
-0.0169 (-1.99%)
After-hours: Dec 10, 2025, 7:15 PM EST
Envoy Medical Employees
Envoy Medical had 42 employees as of December 31, 2024. The number of employees increased by 8 or 23.53% compared to the previous year.
Employees
42
Change (1Y)
8
Growth (1Y)
23.53%
Revenue / Employee
$4,952
Profits / Employee
-$681,214
Market Cap
24.40M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 42 | 8 | 23.53% |
| Dec 31, 2023 | 34 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
COCH News
- 14 hours ago - Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant - Newsfile Corp
- 6 days ago - Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient - Newsfile Corp
- 8 days ago - Envoy Medical Announces the Grant of Its 40th U.S. Patent - Newsfile Corp
- 20 days ago - Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery - Newsfile Corp
- 4 weeks ago - Envoy Medical Reports Third Quarter 2025 Financial and Operational Results - Newsfile Corp
- 5 weeks ago - Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial - Newsfile Corp
- 6 weeks ago - Envoy Medical Marks Three-Year Anniversary of First Patient Receiving Its Breakthrough Fully Implanted Cochlear Implant - Newsfile Corp
- 6 weeks ago - Envoy Medical Receives Positive Listing Determination from NASDAQ - Newsfile Corp